Aqst stock price - View the latest Amesite Inc. (AMST) stock price, news, historical charts, analyst ratings and financial information from WSJ.

 
Is Aquestive Therapeutics Inc stock a Buy or Sell? Get the latest Aquestive Therapeutics Inc Stock Analysis, Price Target, Stock Forecast, and, Analyst Predictions at StockTargetAdvisor!. How to transfer from android to iphone

Real-time Price Updates for Aquestive Therapeutics Inc (AQST-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreThe three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig...View Aquestive Therapeutics (NASDAQ:AQST) historical prices, past price performance, and an advanced AQST stock chart at MarketBeat.Feb 8, 2024 · Aquestive Therapeutics (AQST) ended the recent trading session at $2.68, demonstrating a +1.52% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily ... The Aquestive Therapeutics Inc. stock price gained 2.66% on the last trading day (Monday, 5th Feb 2024), rising from $2.63 to $2.70. During the last trading day the stock fluctuated 5.97% from a day low at $2.57 to a day high of $2.73. The price has been going up and down for this period, and there has been a 7.57% gain for the last 2 …Latest stock price today and the US's most active stock market forums. Aquestive Therapeutics (AQST) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Aquestive Therapeutics Inc stock price (AQST) NASDAQ: AQST. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Aquestive Therapeutics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. NasdaqGM:AQST Stock Report. Market Cap: US$171.6m. Add to watchlist. Company Overview; 1 Valuation; 2 Future Growth; 3 Past Performance; 4 Financial Health; 5 Dividend; 6 Management; 7 Ownership; ... Price target decreased to US$5.50 Nov 16. High number of new and inexperienced directors Nov 16. Price target decreased to US$5.50... stock price by the number of shares outstanding. Aquestive Therapeutics market cap as of February 13, 2024 is $0.18B. Compare AQST With Other Stocks. Sector ...A list of analyst ratings for Aquestive Therapeutics (AQST) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts.Based on our forecasts, a long-term increase is expected, the "AQST" stock price prognosis for 2029-02-14 is 4.030 USD. With a 5-year investment, the revenue is expected to be around +55.6%. Your current $100 investment may be up to $155.6 in 2029. [60% OFF VIP SALE] Portfolio is UP +117% in 2023 - Try Now Risk-Free - Money-back guarantee! ...AQST, $AQST, Aquestive Therapeutics Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend ...AQST - Aquestive Therapeutics, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGM)2,023.90. Crude Oil. Gold. Aquestive Therapeutics, Inc. (AQST) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 2.7500 +0.0700 …Aquestive Therapeutics Inc stock price (AQST) NASDAQ: AQST. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. ... AQST Stock Performance. USD USD; Previous close: 2.51: 2.51: Day range: 2.475 - 2.742.475 - 2.74Year range: 0 - 20 - 2Market cap: 175,598,000: 175,598,000: Primary ...AQST Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for Aquestive Therapeutics in the last 3 months. The average price target is $5.25 with a high forecast of $8.00 and a low forecast of $3.00. The average price target represents a 96.63% change from the last price of $2.67. Nov 16, 2023 · Aquestive Therapeutics (AQST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. The latest trading session saw Aquestive Therapeutics (AQST) ending at $2.63, denoting a -1.5% adjustment from its last day's close. This change lagged the S&P 500's daily gain of 1.07%.Jan 23, 2024 · The latest trading session saw Aquestive Therapeutics (AQST Quick Quote AQST - Free Report) ending at $2.50, denoting a -0.4% adjustment from its last day's close.This change lagged the S&P 500's ... The Aquestive Therapeutics, Inc. stock price is closed at $ 2.68 with a total market cap valuation of $ 178.94M (66.77M shares outstanding). The Aquestive Therapeutics, Inc. is trading on NASDAQ with the sign AQST. Aquestive Therapeutics, Inc. price is up 1.13% in the past 24 hours.The 3 analysts with 12-month price forecasts for AQST stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 120.59% from the current stock price of 2.72.Aquestive Therapeutics Stock Forecast, AQST stock price prediction. Price target in 14 days: 3.027 USD. The best long-term & short-term Aquestive ...AQST Stock Price Chart Interactive Chart >. Growth is the dimension where AQST ranks best; there it ranks ahead of 98.06% of US stocks. The strongest trend for AQST is in Growth, which has been heading up over the past 26 weeks. AQST's current lowest rank is in the Momentum metric (where it is better than 6.62% of US stocks).Find the latest Aquestive Therapeutics, Inc. (AQST) stock quote, history, news and other vital information to help you with your stock trading and investing.2,023.90. Crude Oil. Gold. Aquestive Therapeutics, Inc. (AQST) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 2.7500 +0.0700 …What is the AQST stock price prediction for next 2 weeks? According to our price prediction algorithm,Aquestive Therapeutics, Inc. (AQST) price will be around $2.59 in the next 2 weeks. This means it will ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/6/23. Get the latest Aquestive Therapeutics Inc (AQST) real-time quote, historical performance, charts, and other financial information to help you... Dec 13, 2023 ... ... aqst price analysis 47:30 Outro ▻▻TRADING ALPHA READY TO TRADE LIKE ... 39:26 Back to $AVAX price analysis 39:52 #kas price analysis 41:15 ...Jan 14, 2024 ... ... aqst #mpw #capt #poet #wkhs #hkit #aqststock #mpwstock # ... $CETY STOCK PRICE PREDICTION | DO THIS TOMMOROW. Banking With Billy ...Dec 13, 2023 · The stock's year-to-date return is 25.9%. The consensus estimate for Dynavax Technologies' current year EPS has increased 49.3% over the past three months. The stock currently has a Zacks Rank #2 ... $2.695 USD. -0.025 -0.92% AFTER HOURS 7:59 PM EST 02/16/24. $2.80 0.105. AFTER HOURS Vol 29,301. Volume 499,495. 65 Day Avg Vol 622,430. 1 Day Range 2.66 - …Aquestive Therapeutics (AQST) closed at $2.68 in the latest trading session, marking a +1.13% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.96%.Feb 1, 2024 ... ... stock price well above as well! $AQST - stock I covered a bit ago and it seems like it is ready to run again! Did a great job holding the 8 ...Aquestive Therapeutics (AQST) Stock Price, News & Analysis. $2.75. +0.07 (+2.61%) (As of 02/9/2024 ET) Compare. Share. Today's Range. $2.68. . $2.83. 50-Day …Aquestive (AQST) announces FDA acceptance of a regulatory application seeking approval for Libervant to treat pediatric patients with frequent seizure activity. The stock rises 4.7% in response.Jan 8, 2024 ... You can get these videos early and ad-free by becoming a member at https://m.youtube.com/@walkaboutswithdan/join?noapp=1 ❤️ If you enjoyed ...Aquestive Therapeutics (AQST) closed the most recent trading day at $1.52, moving -0.65% from the previous trading session. This change lagged the S&P 500's 0.02% gain on the day.In terms of how AQUESTIVE THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 124.47% of that group. AQST has a greater average analyst price target than 152.13% of all US stocks.The stock fell short of the S&P 500, which registered a gain of 1.05% for the day. Meanwhile, the Dow gained 0.67%, and the Nasdaq, a tech-heavy index, added 1.64%.The above table shows the analyst AQST forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$2.63AQST. About AQST. Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to …Jan 14, 2024 ... ... aqst #mpw #capt #poet #wkhs #hkit #aqststock #mpwstock # ... $CETY STOCK PRICE PREDICTION | DO THIS TOMMOROW. Banking With Billy ...View the latest Amesite Inc. (AMST) stock price, news, historical charts, analyst ratings and financial information from WSJ.Aquestive Therapeutics, Inc. Common Stock (AQST) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. AQST - Aquestive Therapeutics Inc Stock Price and Quote. Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. AQST. Aquestive …Aquestive Therapeutics Announces Expert Allergy Scientific Advisory Board. (GlobeNewswire) Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients' therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305 ... Buy Aquestive Therapeutics Inc Shares from India at $2.57 (0 Commission) today. Start investing in Aquestive Therapeutics Inc stocks from India now with fractional investing only on INDmoneyappAQST - Aquestive Therapeutics, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGM)The latest trading session saw Aquestive Therapeutics (AQST) ending at $2.63, denoting a -1.5% adjustment from its last day's close. This change lagged the S&P 500's daily gain of 1.07%.Aquestive Therapeutics ( NASDAQ: AQST) is scheduled to announce Q3 earnings results on Monday, November 6th, after market close. The consensus EPS Estimate is -$0.11 (+52.2% Y/Y) and the consensus ...Aquestive Therapeutics, Inc. reported financial results for Q3 2023, with a 25% YoY growth in year-to-date revenue. They raised their full year 2023 revenue guidance to $47-$50 million and improved non-GAAP adjusted EBITDA loss guidance. Aquestive also reiterated the commencement of a pivotal PK study for Anaphylm™ (epinephrine) …Dec 6, 2023 ... Aquestive Therapeutics Inc (AQST) stock is trading at $2.12 as of 1:40 PM on Wednesday, Dec 6, a loss of -$0.27, or -11.3% from the previous ...About the Aquestive Therapeutics Inc stock forecast. As of 2024 February 16, Friday current price of AQST stock is 2.720$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Aquestive Therapeutics stock price as been showing a rising tendency so we believe that similar market …The latest trading session saw Aquestive Therapeutics (AQST) ending at $2.63, denoting a -1.5% adjustment from its last day's close. This change lagged the S&P 500's daily gain of 1.07%.Pipeline. Aquestive Therapeutics is the undisputed leader in developing and delivering medications via film, through our proprietary PharmFilm® technology. We’ve used our expertise to create a robust, proprietary, and complex molecule portfolio. Learn about the medicines we’re reinventing to improve treatment options for patients.5 days ago · During the last trading day the stock fluctuated 10.04% from a day low at $2.45 to a day high of $2.70. The price has been going up and down for this period, and there has been a -10.04% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. NasdaqGM:AQST Stock Report. Market Cap: US$171.6m. Add to watchlist. Company Overview; 1 Valuation; 2 Future Growth; 3 Past Performance; 4 Financial Health; 5 Dividend; 6 Management; 7 Ownership; ... Price target decreased to US$5.50 Nov 16. High number of new and inexperienced directors Nov 16. Price target decreased to US$5.50AQST Stock Price Chart Interactive Chart >. Growth is the dimension where AQST ranks best; there it ranks ahead of 98.06% of US stocks. The strongest trend for AQST is in Growth, which has been heading up over the past 26 weeks. AQST's current lowest rank is in the Momentum metric (where it is better than 6.62% of US stocks). Viad Corp. 32.69. -1.35. -3.97%. Novavax stock remains under pressure despite winning a key designation for its malaria shot. Is NVAX stock a buy or a sell right now? AQST and VVI made it to the ...AQST) stock’s latest price update. Aquestive Therapeutics Inc (NASDAQ: AQST)’s stock price has plunge by 4.78relation to previous closing price of 2.51. Nevertheless, the company has seen a -1.87% plunge in its stock price over the last five trading sessions.Sep 29, 2023 · Aquestive Therapeutics Inc stock is currently priced at $2.57, with a 24-hour trading volume of 4.58M. It has seen a -2.28% decreased in the last 24 hours and a +2.80% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $2.66 pivot point. If it approaches the $2.53 support level, significant changes ... When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks...In the latest trading session, Aquestive Therapeutics (AQST) closed at $2.65, marking a -1.67% move from the previous day. Find the latest Aquestive Therapeutics, Inc. (AQST) stock quote,... Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...NasdaqGM:AQST Stock Report. Market Cap: US$171.6m. Add to watchlist. Company Overview; 1 Valuation; 2 Future Growth; 3 Past Performance; 4 Financial Health; 5 Dividend; 6 Management; 7 Ownership; ... Price target decreased to US$5.50 Nov 16. High number of new and inexperienced directors Nov 16. Price target decreased to US$5.50The Aquestive Therapeutics, Inc. stock price is closed at $ 2.68 with a total market cap valuation of $ 178.94M (66.77M shares outstanding). The Aquestive Therapeutics, Inc. is trading on NASDAQ with the sign AQST. Aquestive Therapeutics, Inc. price is up 1.13% in the past 24 hours.NasdaqGM:AQST Stock Report. Market Cap: US$171.6m. Add to watchlist. Company Overview; 1 Valuation; 2 Future Growth; 3 Past Performance; 4 Financial Health; 5 Dividend; 6 Management; 7 Ownership; ... Price target decreased to US$5.50 Nov 16. High number of new and inexperienced directors Nov 16. Price target decreased to US$5.50Based on our forecasts, a long-term increase is expected, the "AQST" stock price prognosis for 2029-02-14 is 4.030 USD. With a 5-year investment, the revenue is expected to be around +55.6%. Your current $100 investment may be up to $155.6 in 2029. [60% OFF VIP SALE] Portfolio is UP +117% in 2023 - Try Now Risk-Free - Money-back guarantee! ...Jan 5, 2024 ... Maintaining these prices will be difficult to achieve as this level of revenue growth is likely to weigh down the shares eventually. The Key ...5 days ago · The 3 analysts with 12-month price forecasts for AQST stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 139.04% from the current stock price of 2.51. Interactive stock price chart for Aquestive Therapeutics, Inc. (AQST) with real-time updates, full price history, technical analysis and more.AQST stock quote, chart and news. Get AQST's stock price today.Sep 6, 2022 ... Related Stocks. AQST. 2.65. -0.05 (-1.67%). 08:00:00 PM. Aquestive ... stock. price target chart. This current average has increased by 2.69 ...Aquestive Therapeutics (AQST) closed at $1.32 in the latest trading session, marking a -0.75% move from the prior day.3 days ago · 3 analysts have issued 1-year price targets for Aquestive Therapeutics' shares. Their AQST share price targets range from $4.00 to $8.00. On average, they predict the company's stock price to reach $6.00 in the next year. This suggests a possible upside of 118.2% from the stock's current price. NASDAQ · 01/08 07:11. Webull offers AQST Ent Holdg (AQST) historical stock prices, in-depth market analysis, NASDAQ: AQST real-time stock quote data, in-depth charts, free AQST options chain data, and a fully built financial calendar to help you invest smart. Buy AQST stock at Webull.Dec 13, 2023 · The stock's year-to-date return is 25.9%. The consensus estimate for Dynavax Technologies' current year EPS has increased 49.3% over the past three months. The stock currently has a Zacks Rank #2 ... Aquestive Therapeutics, Inc. ( NASDAQ:AQST – Get Free Report )’s share price dropped 0.4% on Tuesday . The stock traded as low as $2.47 and last traded at $2.50. Approximately 457,948 shares ...Aquestive Therapeutics, Inc. is a specialty pharmaceutical company focused on identifying, developing, and commercializing differentiated products to address unmet medical needs. The company has a late-stage proprietary product pipeline focused on the treatment of Central nervous system (CNS) diseases, as well as orally-administered complex ... Nov 27, 2023 · For AQST, shares are up 2.98% over the past week while the Zacks Medical - Drugs industry is up 2.79% over the same time period. Shares are looking quite well from a longer time frame too, as the ...

View the AQST premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aquestive Therapeutics Inc real time stock price chart below. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view .... Jeris johnson

aqst stock price

The stock fell short of the S&P 500, which registered a gain of 1.05% for the day. Meanwhile, the Dow gained 0.67%, and the Nasdaq, a tech-heavy index, added 1.64%.Track Aquestive Therapeutics Inc (AQST) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Find the latest Aquestive Therapeutics, Inc. (AQST) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock information. In July 2018, the Company closed an IPO and began trading on the Nasdaq® Global Market under ticker symbol “AQST”. Stock Information. Change. Volume. 52 Week High. 52 Week Low. Feb 11, 2024 1:11 AM EST. Data Provided by Refinitiv. Minimum 15 minutes delayed.View live Aquestive Therapeutics, Inc. chart to track its stock's price action. Find market predictions, AQST financials and market news. Aquestive Therapeutics (AQST) closed at $2.39 in the latest trading session, marking a +0.84% move from the prior day. The stock's performance was ahead of the S&P 500's daily loss of 0.07%.AQST stock quote, chart and news. Get AQST's stock price today.AQST stock quote, chart and news. Get AQST's stock price today.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...Predictions of AQST stock price for tomorrow. StockInvest.us is a research service that provides financial data and technical analysis of publicly traded stocks.Aquestive Therapeutics, Inc. Common Stock (AQST) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Track Aquestive Therapeutics Inc (AQST) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors View Aquestive Therapeutics (NASDAQ:AQST) historical prices, past price performance, and an advanced AQST stock chart at MarketBeat..

Popular Topics